TOP 94
SAN DIEGO- It would not be difficult to list 94 important stories from
the world of science research for the past year. The pace of research in
most areas continues to increase, meaning that the amount of new information
has become a virtual flood. However, in the interest of brevity and prevention
of data overload, here is a quick review of some of the top science stories
in 1994.
GENES A multitude of genes, human and otherwise, were identified
and their functions described over the past 12 months. These included: Ob,
a gene predisposing to obesity; BCR, a breast cancer susceptibility gene;
BCL-2, a gene associated with apoptosis (programmed cell death); hedgehog
genes (so named because of their shape, these produce proteins which guide
cell differentiation in advanced organisms); and Vpr, a gene governing reproduction
of the HIV virus.
Linkage studies identified genes for a variety of ailments including:
bipolar disorder, cerulean cataracts, melanoma, hearing loss, dyslexia,
thyroid cancer, sudden infant death syndrome, prostate cancer and dwarfism.
Cystic fibrosis was very newsworthy in 1994. Genetic researchers successfully
transferred the CFTR (cystic fibrosis transmembrane conductance regulator)
gene into the intestines of mice. This appears to be a major step towards
gene therapy for patients with cystic fibrosis. In a related development,
researchers reported early success with a liposomal method for delivering
the CFTR gene in humans. The past year also saw the approval of genetically
engineered version of human DNAase, which breaks down protein accumulation
in the lungs of CF patients. The once-a-day aerosol spray reportedly provides
significant symptomatic relief.
Researchers also reported a number of important developments in gene
inhibition. One group reported using synthetic DNA decoys to mimic transcription
factors, blocking transcription of the gene. Another group of researchers
reported the first successful systemic selective inhibition of gene expression
using antisense oligonucleotides.
The Human Genome
Project continued its massive efforts to characterize human genes. 1994
saw the first crude but thorough linkage map
of the human genome (See Science, v.265, Sep.30, '94, for the full color
pull-out). The year also saw an increase in squabbling over who owns what
parts of the genome. The scientists and research corporations have worked
out a way to share access to a computerized database detailing 35,000 human
genes.
AIDS
The numbers of AIDS cases continued to increase worldwide and in the
US in 1994. The epidemic's rate of growth appears to be slowing in the US,
but is increasingly rapidly in Asia.
A couple of positive findings were reported at the International AIDS
conference in Yokohama. One large study confirmed that administration of
the nucleoside analog zidovudine (AZT) in pregnant HIV positive mothers
prevents transmission of HIV to the fetus. In another interesting report,
researchers identified immune system characteristics in long term nonprogressors,
people who never develop immune or other signs of HIV disease ins spite
of being infected. Those observations could help with development of new
treatment and vaccines. Also, 1994 saw the first attempts at gene therapy
vaccines for AIDS in early clinical testing.
CANCER
A discovery reported in the last month of the year may have far reaching
significance in cancer research. Researchers at the University of Texas
reported that the enzyme telomerase appears to be responsible for the unchecked
growth of cells seen in human cancers. The discovery could lead to many
new diagnostic and therapeutic applications.
In the clinical world, anti-melanoma vaccines appear to show promise.
One vaccine candidate now in advanced clinical trials has produced longer
survival in patients with this, the most tenacious and difficult to treat
cancer. Another vaccine candidate using retrovirus
-mediated gene transfer has just recently entered clinical trials.
HEART
A number of genes associated with atherosclerosis, high cholesterol and
high blood pressure were identified. Studies also showed that therapy with
cholesterol lowering drugs can not only halt progression of atherosclerosis,
it can reverse it, reducing the risk for heart attack. Another study showed
that Vitamin E could reduce the risk for stroke in high risk patients.
MIND
A new class of drugs, selective serotonin re-uptake inhibitors, (e.g.
Prozac), became available. In addition to providing a powerful treatment
for chronic depression, the new class of drugs has taught neurochemists
much about the biology of moods
FOOD
The first genetically engineered food product, the FlavrSavr tomato,
gained FDA approval and reached supermarkets in 1994.
ENVIRONMENT
The worst oil spill in history was reported in Northern Siberia. The
full extent of the environmental damage from the damaged pipeline will not
be known until this Spring. Estimates run as high as 80 million gallons
spilled, compared with 11 million gallon for the Exxon Valdez.
On a more hopeful note, the national bird, the Bald Eagle, came back
from near extinction, moving up from the endangered list to the threatened
list.
ELEMENTS
Two new elements, 110 and 111, were identified by German scientists.
They have not been named yet.
UP IN THE SKY
The world was treated to a spectacular show as the comet Shoemaker-Levi
9 crashed full speed into Jupiter's atmosphere. The images were viewed live
by many people via the Internet.
BONES
The oldest human fossil yet (4.4 million years old) , Australopithecus
ramidus, was discovered in Ethiopia.
EDUCATION
The draft of the NAS science education standards for levels K-12 was
released in December of 1994. The standards, now subject toreview and amendment
by focus groups across the country represent an unprecedented collaboration
among scientists, teachers and education specialists.
LAST BUT NOT LEAST
The power of the Internet for communications and information exchange
lured hundreds of thousands of newbies into cyberspace. A new online service
called Access Excellence debuted on America Online, dedicated to linking
teachers and scientists through interactive computer exchange.
|